As such, it is possible that loss of Adamts12 with subsequent loss of CD200/CD200R fibroblast-macrophage signaling leads to a dysfunctional attenuation of inflammation in response to other stimuli, i.e., in infection and autoimmune disease, but not fibrosis. The gene discussed is ADAMTS12; the disease is autoimmune disease.